메뉴 건너뛰기




Volumn 20, Issue 8, 2013, Pages 311-318

Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route

Author keywords

Active mesh nebulizer; Liposomes; Nebulization; Radiolabeling; Route

Indexed keywords

CHOLESTEROL; OCTADECYLAMINE; PHOSPHOLIPID; RISEDRONIC ACID;

EID: 84885628951     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.835160     Document Type: Article
Times cited : (40)

References (26)
  • 1
    • 68749119666 scopus 로고    scopus 로고
    • Cationic liposomes as carriers for aerosolized formulations of an anionic drug: Safety and efficacy study
    • Bai S, Gupta V, Ahsan F. (2009). Cationic liposomes as carriers for aerosolized formulations of an anionic drug: safety and efficacy study. Eur J Pharm Sci 38: 165-71.
    • (2009) Eur J Pharm Sci , vol.38 , pp. 165-171
    • Bai, S.1    Gupta, V.2    Ahsan, F.3
  • 2
    • 65749090177 scopus 로고    scopus 로고
    • Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate
    • Blumentals WA, Harris ST, Cole RE, et al. (2009). Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate. Ann Pharmacother 43: 577-85.
    • (2009) Ann Pharmacother , vol.43 , pp. 577-585
    • Blumentals, W.A.1    Harris, S.T.2    Cole, R.E.3
  • 3
    • 0028954464 scopus 로고
    • The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers
    • Clark AR. (1995). The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers. Int J Pharm 115: 69-78.
    • (1995) Int J Pharm , vol.115 , pp. 69-78
    • Clark, A.R.1
  • 4
    • 41849123834 scopus 로고    scopus 로고
    • Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: Time-dependent inhibition of human farnesyl pyrophosphate synthase
    • DOI 10.1021/jm7015733
    • Dunford JE, Kwaasi AA, Rogers MJ, et al. (2008). Structureactivity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase. J Med Chem 51: 2187-95. (Pubitemid 351503274)
    • (2008) Journal of Medicinal Chemistry , vol.51 , Issue.7 , pp. 2187-2195
    • Dunford, J.E.1    Kwaasi, A.A.2    Rogers, M.J.3    Barnett, B.L.4    Ebetino, F.H.5    Russell, R.G.G.6    Oppermann, U.7    Kavanagh, K.L.8
  • 7
    • 0034739243 scopus 로고    scopus 로고
    • Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption
    • DOI 10.1016/S0169-409X(00)00061-2, PII S0169409X00000612
    • Ezra A, Golomb G. (2000). Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption. Adv Drug Deliv Rev 42: 175-95. (Pubitemid 30645777)
    • (2000) Advanced Drug Delivery Reviews , vol.42 , Issue.3 , pp. 175-195
    • Ezra, A.1    Golomb, G.2
  • 8
    • 77149157841 scopus 로고    scopus 로고
    • Generation of liposome aerosols with the aeroneb pro and the aeroprobe nebulizers
    • Gaspar MM, Gobbo O, Ehrhardt C. (2010). Generation of liposome aerosols with the Aeroneb Pro and the AeroProbe nebulizers. J Liposome Res 20: 55-61.
    • (2010) J Liposome Res , vol.20 , pp. 55-61
    • Gaspar, M.M.1    Gobbo, O.2    Ehrhardt, C.3
  • 9
    • 33846557959 scopus 로고    scopus 로고
    • Liposomes as an ocular delivery system for acetazolamide: In vitro and in vivo studies
    • Hathout RM, Mansour S, Mortada ND, Guinedi AS. (2007). Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech 8:1.
    • (2007) AAPS PharmSciTech , vol.8 , pp. 1
    • Hathout, R.M.1    Mansour, S.2    Mortada, N.D.3    Guinedi, A.S.4
  • 10
    • 77953022632 scopus 로고    scopus 로고
    • Microemulsion formulations for the transdermal delivery of testosterone
    • Hathout RM, Woodman TJ, Mansour S, et al. (2010). Microemulsion formulations for the transdermal delivery of testosterone. Eur J Pharm Sci 40: 188-96.
    • (2010) Eur J Pharm Sci , vol.40 , pp. 188-196
    • Hathout, R.M.1    Woodman, T.J.2    Mansour, S.3
  • 11
    • 33644902058 scopus 로고    scopus 로고
    • Determination of risedronate in rat plasma samples by ion-pair high-performance liquid chromatography with uv detector
    • Jia HJ, Li W, Zhao K. (2006). Determination of risedronate in rat plasma samples by ion-pair high-performance liquid chromatography with UV detector. Analytica Chimica Acta 562: 171-5.
    • (2006) Analytica Chimica Acta , vol.562 , pp. 171-175
    • Jia, H.J.1    Li, W.2    Zhao, K.3
  • 13
    • 54949109737 scopus 로고    scopus 로고
    • Pulmonary delivery of scutellarin solution and mucoadhesive particles in rats
    • Liu X-B, Ye J-X, Quan L-H, et al. (2008). Pulmonary delivery of scutellarin solution and mucoadhesive particles in rats. Eur J Pharm Biopharm 70: 845-52.
    • (2008) Eur J Pharm Biopharm , vol.70 , pp. 845-852
    • Liu, X.-B.1    Ye, J.-X.2    Quan, L.-H.3
  • 15
    • 38049009486 scopus 로고    scopus 로고
    • Structural determinants of water permeability through the lipid membrane
    • Mathai JC, Trsitram-Nagle S, Nagle JF, Zeidel ML. (2008). Structural determinants of water permeability through the lipid membrane. J Gen Physiol 131: 69-76.
    • (2008) J Gen Physiol , vol.131 , pp. 69-76
    • Mathai, J.C.1    Trsitram-Nagle, S.2    Nagle, J.F.3    Zeidel, M.L.4
  • 16
    • 19544376123 scopus 로고    scopus 로고
    • Optimizing the management of postmenopausal osteoporosis with bisphosphonates: The emerging role of intermittent therapy
    • DOI 10.1016/j.clinthera.2005.04.005, PII S0149291805000615
    • Miller PD. (2005). Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy. Clin Ther 27: 361-76. (Pubitemid 40732645)
    • (2005) Clinical Therapeutics , vol.27 , Issue.4 , pp. 361-376
    • Miller, P.D.1
  • 18
    • 80053950940 scopus 로고    scopus 로고
    • Different modalities of nacl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting
    • Nasr M, Awad GAS, Mansour S, et al. (2011). Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting. Eur J Pharm Biopharm 79: 601-11.
    • (2011) Eur J Pharm Biopharm , vol.79 , pp. 601-611
    • Nasr, M.1    Awad, G.A.S.2    Mansour, S.3
  • 19
    • 84885668475 scopus 로고    scopus 로고
    • Hydrophilic versus hydrophobic porogens for engineering of poly(lactide-co-glycolide) microparticles containing risedronate sodium
    • Nasr M, Awad GAS, Mansour S, et al. (2013). Hydrophilic versus hydrophobic porogens for engineering of poly(lactide-co-glycolide) microparticles containing risedronate sodium. Pharm Dev Technol 18: 1078-88.
    • (2013) Pharm Dev Technol , vol.18 , pp. 1078-1088
    • Nasr, M.1    Awad, G.A.S.2    Mansour, S.3
  • 20
    • 54049121401 scopus 로고    scopus 로고
    • Vesicular aceclofenac systems: A comparative study between liposomes and niosomes
    • Nasr M, Mansour S, Mortada ND, Elshamy AA. (2008). Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsulation 25: 499-512.
    • (2008) J Microencapsulation , vol.25 , pp. 499-512
    • Nasr, M.1    Mansour, S.2    Mortada, N.D.3    Elshamy, A.A.4
  • 21
    • 84865293519 scopus 로고    scopus 로고
    • Amphotericin b lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization
    • Nasr M, Nawaz S, Elhissi A. (2012). Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization. Int J Pharm 436: 611-16.
    • (2012) Int J Pharm , vol.436 , pp. 611-616
    • Nasr, M.1    Nawaz, S.2    Elhissi, A.3
  • 22
    • 0032444335 scopus 로고    scopus 로고
    • Fluid phase structure of EPC and DMPC bilayers
    • DOI 10.1016/S0009-3084(98)00068-1, PII S0009308498000681
    • Petrache HI, Tristram-Nagle S, Nagle JF. (1998). Fluid phase structure of EPC and DMPC bilayers. Chem Phys Lipids 95: 83-94. (Pubitemid 29034720)
    • (1998) Chemistry and Physics of Lipids , vol.95 , Issue.1 , pp. 83-94
    • Petrache, H.I.1    Tristram-Nagle, S.2    Nagle, J.F.3
  • 23
    • 0020466629 scopus 로고
    • Cholesterol-phospholipid interaction in membranes. 1. Cholestane spin-label studies of phase behavior of cholesterol-phospholipid liposomes
    • DOI 10.1021/bi00259a016
    • Presti FT, Chan SI. (1982). Cholesterol-phospholipid interaction in membranes. 1. Cholestane spin-label studies of the phase behavior of cholesterol-phospholipid liposomes. Biochemistry 21: 3821-30. (Pubitemid 13230950)
    • (1982) Biochemistry , vol.21 , Issue.16 , pp. 3821-3830
    • Presti, F.T.1    Pace, R.J.2    Chan, S.I.3
  • 24
    • 0020401564 scopus 로고
    • Cholesterol-phospholipid interaction in membranes. 2. Stoichiometry and molecular packing of cholesterol-rich domains
    • DOI 10.1021/bi00259a017
    • Presti FT, Pace RJ, Chan SI. (1982). Cholesterol-phospholipid interaction in membranes. 2. Stoichiometry and molecular packing of cholesterol-rich domains. Biochemistry 21: 3831-5. (Pubitemid 13230951)
    • (1982) Biochemistry , vol.21 , Issue.16 , pp. 3831-3835
    • Presti, F.T.1    Chan, S.I.2
  • 25
    • 33750845387 scopus 로고    scopus 로고
    • In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery
    • DOI 10.1016/j.addr.2006.07.012, PII S0169409X06001463
    • Sakagami M. (2006). In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev 58: 1030-60. (Pubitemid 44712023)
    • (2006) Advanced Drug Delivery Reviews , vol.58 , Issue.9-10 , pp. 1030-1060
    • Sakagami, M.1
  • 26
    • 84865282526 scopus 로고    scopus 로고
    • Design, optimization and in vitro evaluation of reverse-micelle loaded lipid nanocarriers containing erlotinib hydrochloride
    • Vrignaud S, Hureaux J, Wack S, et al. (2012). Design, optimization and in vitro evaluation of reverse-micelle loaded lipid nanocarriers containing erlotinib hydrochloride. Int J Pharm 436: 194-200.
    • (2012) Int J Pharm , vol.436 , pp. 194-200
    • Vrignaud, S.1    Hureaux, J.2    Wack, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.